Compare RYN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYN | RGEN |
|---|---|---|
| Founded | 1926 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.6B |
| IPO Year | 1994 | 1995 |
| Metric | RYN | RGEN |
|---|---|---|
| Price | $21.04 | $126.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $26.00 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 2.4M | 928.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 11.73% | N/A |
| EPS Growth | 26.78 | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $484,485,000.00 | $141,236,000.00 |
| Revenue This Year | $214.97 | $14.30 |
| Revenue Next Year | $10.35 | $14.52 |
| P/E Ratio | ★ N/A | $880.13 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $19.49 | $100.99 |
| 52 Week High | $27.34 | $175.77 |
| Indicator | RYN | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 51.33 |
| Support Level | $20.99 | $111.09 |
| Resistance Level | $21.57 | $131.53 |
| Average True Range (ATR) | 0.53 | 5.57 |
| MACD | 0.02 | 0.27 |
| Stochastic Oscillator | 34.17 | 42.86 |
Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.